Aptose Biosciences Inc. Quarterly Common Stock, Shares, Issued from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Aptose Biosciences Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2017 to Q3 2024.
  • Aptose Biosciences Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 19.5M shares, a 159% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 19.5M +12M +159% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 18.1M +11.7M +184% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 15.7M -77.3M -83.1% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 7.94M +1.78M +29% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 7.54M -84.8M -91.8% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 6.38M -85.9M -93.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 93M +776K +0.84% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 6.16M -86.1M -93.3% Dec 31, 2022 10-K 2024-03-26
Q3 2022 92.3M +3.35M +3.76% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 92.3M +3.31M +3.72% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 92.2M +3.31M +3.72% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 92.2M +3.33M +3.75% Dec 31, 2021 10-K 2023-03-24
Q3 2021 88.9M +87K +0.1% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 88.9M +12.7M +16.6% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 88.9M +12.7M +16.6% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 88.9M +12.8M +16.8% Dec 31, 2020 10-K 2022-03-22
Q3 2020 88.9M +33.4M +60.2% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 76.3M +20.9M +37.6% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 76.3M -41.4B Mar 31, 2020 10-Q 2020-05-05
Q4 2019 76.1M +37.9M +99.4% Dec 31, 2019 10-K 2021-03-23
Q3 2019 55.5M +20.5M +58.5% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 55.4M +21M +61.1% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 41.5B* +41.5B Mar 31, 2019 10-Q 2019-05-07
Q4 2018 38.2M +10.7M +38.8% Dec 31, 2018 10-K 2020-03-10
Q3 2018 35M Sep 30, 2018 8-K 2019-03-12
Q2 2018 34.4M Jun 30, 2018 8-K 2019-03-12
Q1 2018 30.7M Mar 31, 2018 8-K 2019-03-12
Q4 2017 27.5M Dec 31, 2017 8-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.